BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27222534)

  • 1. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
    Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
    Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
    Todt D; Walter S; Brown RJ; Steinmann E
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
    Haldipur B; Bhukya PL; Arankalle V; Lole K
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
    Todt D; Meister TL; Steinmann E
    Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
    Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
    Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
    Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
    Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
    Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
    Goyal R; Kumar A; Panda SK; Paul SB; Acharya SK
    Antivir Ther; 2012; 17(6):1091-6. PubMed ID: 22910532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin.
    Ambrosioni J; Mamin A; Hadengue A; Bernimoulin M; Samii K; Landelle C; Negro F; Kaiser L
    Clin Microbiol Infect; 2014 Oct; 20(10):O718-20. PubMed ID: 24476456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.
    Lhomme S; Kamar N; Nicot F; Ducos J; Bismuth M; Garrigue V; Petitjean-Lecherbonnier J; Ollivier I; Alessandri-Gradt E; Goria O; Barth H; Perrin P; Saune K; Dubois M; Carcenac R; Lefebvre C; Jeanne N; Abravanel F; Izopet J
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1608-14. PubMed ID: 26711757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
    Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
    J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.